YKS-34

YKS-34 is an orally active PDE4B inhibitor (IC50 = 1.71 nM). YKS-34 inhibits LPS-induced TNF-α release in PBMCs and TGF-β-induced fibroblast activation by reducing Cyclic AMP (cAMP) (HY-B1511) hydrolysis and elevating cAMP signaling. YKS-34 dose-dependently improves lung function and attenuates fibrotic remodeling in Bleomycin (HY-108345)-induced pulmonary fibrosis mouse models, and it accumulates in lung tissue, shows limited brain exposure, does not induce emetic episodes in beagles, and exhibits weak inhibition of the hERG channel. YKS-34 can be used for research on idiopathic pulmonary fibrosis.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Formel: C22H16DClF3N3O5S
  • Molecular Weight:528.91
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00